Basic Information
ID: ALA4009405
Type: ADME
Description: Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis
Format: BAO_0000219
Organism: Homo sapiens
Target: Adenosine kinase(ALA3589)
Document: ALA4007430
Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4009405
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 455.39 | 1.10 | 1.10 |